ImStem Biotechnology, Inc., a biopharmaceutical company developing human embryonic stem cell (ESC)-derived mesenchymal stem cells, has dosed the first U.S. multiple sclerosis (MS) patient with…
Posts published by “Dennis Carey”
As a significant contributor and a thorough public health professional, Dennis's professional profile is highly impressive and his association as a contributing writer at Health Rapid is highly valued. He has considerable experience in writing for various medical and scientific documents such as literature reviews, scientific publications and is best known for his tremendous contribution as a medical writer. He also has significant experience for writing in government websites such as the National Institutes of Health which explains his sheer mettle and accuracy.
Today, Tiamat Sciences, a Biotechnology startup, announced a $3 million seed funding round headed by True Ventures of Silicon Valley, with participation from Social Impact…
With a $1 billion asset deal with Arrowhead Pharmaceuticals, GlaxoSmithKline is making its first big step into treating nonalcoholic steatohepatitis (NASH), a fatty liver disease.…
Nuritas, a Dublin-based biotech firm that employs proprietary AI to find plant-based bioactive peptides, has raised $45 million (about €39 million) in a Series B…
Near the train station, Millbrae is getting two new biotech complexes, with a proposal for a life-science campus at 201 and 231 Adrian Road and…
Merck antiviral molnupiravir for covid-19 has showed positive results. Thus it has continued to pay off through supply deals. J&J has inked a deal of…
For Alessandro Riva, M.D., the pharmaceutical and biotech industries have been a revolving door since 2017. Now, he’s been hired as the future CEO of…
Many of the rarest and most difficult-to-treat diseases are caused by a single gene mutation, making routine pharmaceutical and surgical treatments ineffective. On the other…
A Hammond-based biotechnology firm collaborates with the University of Western Australia to research medications to treat neurodegenerative disorders and the pain associated with spinal cord…
Autumn is in full swing for those who live in leafy areas, and it appears that Vertex is too: the pharma has struck another CRISPR…